Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6N4O.CH4O3S |
Molecular Weight | 246.244 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.NC1=CC2=C(N=CN2)C(=O)N1
InChI
InChIKey=ZNTIXVYOBQDFFV-UHFFFAOYSA-N
InChI=1S/C6H6N4O.CH4O3S/c7-4-1-3-5(6(11)10-4)9-2-8-3;1-5(2,3)4/h1-2H,(H,8,9)(H3,7,10,11);1H3,(H,2,3,4)
Molecular Formula | CH4O3S |
Molecular Weight | 96.106 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C6H6N4O |
Molecular Weight | 150.138 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Dezaguanine is a broad spectrum guanine antimetabolite. This compound differs from guanine only in the substitution of a carbon for the 3-nitrogen of guanine. Dezaguanine must be converted to its nucleotides to be active. Dezaguanine nucleotides inhibit synthesis of guanine nucleotides, and can be incorporated into nucleic acids in place of guanine nucleotides; incorporation into DNA may be particularly important in the cytotoxicity of this compound. Addition of certain purines or purine nucleosides can prevent dezaguanine cytotoxicity in vitro. It has exhibited sufficient preclinical antitumor activity, particularly against rat and mouse mammary adenocarcinomas, slow and fast growing mammary tumors in mice and the human breast xenograft subrenal capsule implant system. It has completed one phase I trial.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid. | 1977 Jul |
|
Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors. | 1978 Dec |
|
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity. | 1982 Jan |
|
Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides. | 1984 Nov |
|
Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro. | 1987 Aug |
|
Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro. | 1987 Feb |
|
Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. | 1989 Sep |
|
Low molecular weight human T-cell response immunopotentiator: alpha-2'-deoxy-3-deazaguanosine. | 1990 |
|
Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. | 1994 Oct |
|
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. | 2000 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4066218
Curator's Comment: Rat data
Dose - 140 mg/kg once daily for 9 days.
Route of Administration:
Intraperitoneal
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:14 UTC 2023
by
admin
on
Fri Dec 15 15:13:14 UTC 2023
|
Record UNII |
H56TJ4554M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1556
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
87434-82-0
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY | |||
|
55709
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY | |||
|
W-21
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY | |||
|
CHEMBL31882
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY | |||
|
DTXSID001007560
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY | |||
|
H56TJ4554M
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY | |||
|
C80635
Created by
admin on Fri Dec 15 15:13:14 UTC 2023 , Edited by admin on Fri Dec 15 15:13:14 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |